Aug 2021- Artificial intelligence has been hailed as the next big thing in drug discovery but to leverage its full potential, the life sciences industry first needs to pay attention to experimental design and data collection.
Aug 2021- Forbes covers the release of the Synthace Life Sciences R&D Cloud, the first no-code software platform for automating experimentation and insight sharing. Read on to learn more about how our platform is transforming life sciences R&D.
First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.
Synthace hires Guy Levy-Yurista as Chief Executive Officer.